ISONG Webinar
May 28, 2014
12:00 - 1:00pm EDT (New York)
Breast Cancer Genetics
Then and Now: Impact on Risk
Assessment and Clinical Care
Deborah J. MacDonald, PhD RN APNG
Genetics/Genomics Cancer Risk Consultant
Dr. Deborah MacDonald is in private practice as
a genetics/genomics cancer risk consultant.
She has worked in genetic cancer risk since
1992, first at the Massachusetts General
Hospital in Boston and then from1997 until late
2012, at the City of Hope Comprehensive Cancer Center in Duarte,
CA where she helped establish the Division of Clinical Cancer
Genetics, was promoted to Assistant Professor in 2008, and served
on the National Comprehensive Cancer Network's Breast Cancer
Risk Reduction Guidelines panel from 2001-2012. For 2013, she
was a Senior Clinical Advisor (contractor) to the National Cancer
Institute, Center for Cancer Research, Genetics Branch. Dr.
MacDonald is an author on more than 50 cancer genetics
publications, was a founding member of the National Society of
Genetic Counselors and the Oncology Nursing Society's cancer
genetics special interest groups, and has held several ISONG
positions including member-at-large, newsletter editor and past
president (1999). She has been credentialed in genetics (APNG)
since 2001.
Description
This webinar introduces breast cancer risk assessment from the
beginning of BRCA gene testing in the mid-90's to the emerging use
of multi-gene panels. Also discussed will be how genetics and
genomics influences breast cancer screening, strategies for
reducing hereditary breast cancer risk, and the diagnosis and
treatment of breast cancer.
Participants attending the entire webinar, completing and returning
the evaluation tool will receive 1 continuing nursing education
contact hour.
Who Should Attend?
RNs new to breast cancer genetics and those who desire to learn
about current strategies for genetic testing for breast cancer risk and
the influence of genetics/genomics on the cancer care continuum
would benefit from this webinar.
Objectives
1. After this presentation, attendees will be able to state at
least 3 key indicators of hereditary risk for breast cancer.
2. After this presentation, attendees will be able to discuss how
genetic testing to identify breast cancer risk has changed
over the past 20 years.
3. After this presentation, attendees will be able to describe
how genetics and genomics influences breast cancer
screening, risk reduction, diagnosis and treatment.
Space is limited, reserve your seat now.
The cost is $25.00 for ISONG Members / $50.00 for Non-members.
Register for this webinar at www.isong.org
This learning activity has been developed in collaboration with the University
of Pittsburgh School of Nursing.
The University of Pittsburgh School of Nursing, is accredited as a provider
of continuing nursing education by the American Nurses Credentialing
Center's Commission on Accreditation.
An unrestricted educational grant was provided by
Myriad Genetics.